Applications of Cyclodextrin-Based Drug Delivery Systems in Inflammation-Related Diseases

作者：Zelan Dai, Huijuan Yang, Peng Yin, X G Liu, Ling Zhang, Youwei Dou, Shibo Sun · 发表于：Pharmaceutics · 年份：2025 · DOI：10.3390/pharmaceutics17030378 · 被引用次数：11 · 研究领域：Drug Solubulity and Delivery Systems、Nanoparticle-Based Drug Delivery、Advanced Drug Delivery Systems

Currently, inflammation diseases are one of the leading causes of mortality worldwide. The therapeutic drugs for inflammation are mainly steroidal and non-steroidal anti-inflammatory drugs. However, the use of these anti-inflammatory drugs over a prolonged period is prone to causing serious side effects. Accordingly, it is particularly critical to design an intelligent target-specific drug delivery system to control the release of drugs in order to mitigate the side effects of anti-inflammatory drugs without limiting their activity. Meanwhile, cyclodextrin-based nano-delivery systems have garnered significant attention in contemporary pharmaceutical research owing to their capacity to enhance drug bioavailability, enable site-specific targeted accumulation, prolong the systemic circulation duration, facilitate synergistic therapeutic outcomes, and exhibit superior biocompatibility profiles. It is worth noting that cyclodextrin-based drug delivery systems show great potential in inflammation-related diseases. However, few studies have systematically reviewed their design strategies and application advancements. Here, we summarize the structural and chemical modification strategies of cyclodextrins, as well as cyclodextrin-based drug delivery systems and their applications in inflammation-related diseases. In summary, the aim is to provide a bit of insight into the development of cyclodextrin-based drug delivery systems for inflammation-related diseases.